Cellular Stress Targeted By Black Belt TX-Praxis Biotech Partnership

A New Mechanism Of Action In Cancer

 
• By John Davis

A strategic partnership active in the hot area of understanding the tumor micro-environment in order to develop new cancer drugs has been formed by two new biotechs, the UK’s Black Belt TX and the US’s Praxis Biotech.  

Black belt
The fight against cancer requires expertise in numerous areas. • Source: Shutterstock

More from Immuno-oncology

More from Anticancer